These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 16603962

  • 1. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
    Schueler AO, Anastassiou G, Jurklies C, Havers W, Wieland R, Bornfeld N.
    Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
    [Abstract] [Full Text] [Related]

  • 2. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
    Wilson MW, Haik BG, Billups CA, Rodriguez-Galindo C.
    Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
    [Abstract] [Full Text] [Related]

  • 3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 4. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA.
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [Abstract] [Full Text] [Related]

  • 5. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 6. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 7. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 8. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 9. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
    Chan MP, Hungerford JL, Kingston JE, Plowman PN.
    Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 11. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N, Schüler A, Bechrakis N, Henze G, Havers W.
    Klin Padiatr; 1997 Mar; 209(4):216-21. PubMed ID: 9293453
    [Abstract] [Full Text] [Related]

  • 12. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

  • 13. New retinoblastoma tumor formation in children initially treated with systemic carboplatin.
    Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH.
    Ophthalmology; 2003 Oct; 110(10):1989-94; discussion 1994-5. PubMed ID: 14522776
    [Abstract] [Full Text] [Related]

  • 14. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy for retinoblastoma.
    Chan HS, Gallie BL, Munier FL, Beck Popovic M.
    Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
    [Abstract] [Full Text] [Related]

  • 16. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP, Shields C, Meadows AT.
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [Abstract] [Full Text] [Related]

  • 17. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K, Pal N, Kosek S, Holm S, All-Ericsson C.
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [Abstract] [Full Text] [Related]

  • 18. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.
    Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442
    [Abstract] [Full Text] [Related]

  • 19. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH.
    Br J Ophthalmol; 2013 Oct 15; 97(10):1277-83. PubMed ID: 23863458
    [Abstract] [Full Text] [Related]

  • 20. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun 15; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.